AMPE Ampio Pharmaceuticals Inc.

0.64
0  0%
Previous Close 0.64
Open 0.65
Price To Book 32.01
Market Cap 68319914
Shares 106,716,516
Volume 402,448
Short Ratio 33.36
Av. Daily Volume 929,586

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Noted August 7, 2018 that further trials required before filing BLA, confirmed December 13, 2018.
Ampion
Osteoarthritis of the Knee
Phase 2b data released May 2015 did not meet endpoints
Optina
Diabetic Macula Edema

SEC Filings

  1. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19604213
  2. SC 13G - Statement of acquisition of beneficial ownership by individuals 19576420
  3. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19558210
  4. 8-K - Current report 181244593
  5. 8-K - Current report 181229983
  6. 8-K - Current report 181224817
  7. 10-Q - Quarterly report [Sections 13 or 15(d)] 181180200
  8. DEF 14A - Other definitive proxy statements 181148598
  9. 8-K - Current report 181106875
  10. 8-K - Current report 181103040